Literature DB >> 20205592

Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells.

Christine M Oshansky1, James P Barber, Jackelyn Crabtree, Ralph A Tripp.   

Abstract

Human respiratory syncytial virus (RSV) is a ubiquitous respiratory virus that causes serious lower respiratory tract disease in infants and young children worldwide. Studies have shown that RSV infection modulates chemokine expression patterns, suggesting that particular cytokine expression profiles may be indicators of disease severity. In this study, we show that RSV F or G protein treatment of fully differentiated primary normal human bronchial epithelial cells induces apical and basolateral secretion of interleukin 8 (IL-8), interferon-inducible protein 10 (IP-10), monocyte chemotactic protein 1 (MCP-1), and RANTES (regulated on activation, normal T cell expressed and secreted). Purified RSV G (attachment) protein was shown to stimulate the secretion of interleukin 1alpha and RANTES, whereas purified F (fusion) protein elicited the production of IL-8, IP-10, and RANTES. Studies of ultraviolet-inactivated RSV showed that treatment of normal human bronchial epithelial cells induces apical IL-8, IP-10, and MCP-1 secretion independent of infection, suggesting that RSV proteins alone modify the chemokine response pattern, which may affect the early immune response before infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20205592      PMCID: PMC2839062          DOI: 10.1086/651431

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

Review 1.  Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB.

Authors:  K A Roebuck; L R Carpenter; V Lakshminarayanan; S M Page; J N Moy; L L Thomas
Journal:  J Leukoc Biol       Date:  1999-03       Impact factor: 4.962

2.  Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice.

Authors:  R A Tripp; D Moore; L Jones; W Sullender; J Winter; L J Anderson
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  Respiratory syncytial virus infection of human respiratory epithelial cells enhances inducible nitric oxide synthase gene expression.

Authors:  H Tsutsumi; R Takeuchi; M Ohsaki; K Seki; S Chiba
Journal:  J Leukoc Biol       Date:  1999-07       Impact factor: 4.962

4.  IL-8 and neutrophil elastase levels in the respiratory tract of infants with RSV bronchiolitis.

Authors:  M Abu-Harb; F Bell; A Finn; W H Rao; L Nixon; D Shale; M L Everard
Journal:  Eur Respir J       Date:  1999-07       Impact factor: 16.671

5.  Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis.

Authors:  L Bont; C J Heijnen; A Kavelaars; W M van Aalderen; F Brus; J T Draaisma; S M Geelen; H J van Vught; J L Kimpen
Journal:  Eur Respir J       Date:  1999-07       Impact factor: 16.671

6.  RSV infection of human airway epithelial cells causes production of the beta-chemokine RANTES.

Authors:  S Becker; W Reed; F W Henderson; T L Noah
Journal:  Am J Physiol       Date:  1997-03

7.  Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease.

Authors:  P Sheeran; H Jafri; C Carubelli; J Saavedra; C Johnson; K Krisher; P J Sánchez; O Ramilo
Journal:  Pediatr Infect Dis J       Date:  1999-02       Impact factor: 2.129

8.  Respiratory syncytial virus triggers synthesis of IL-6 in BALB/c mouse alveolar macrophages in the absence of virus replication.

Authors:  A W Stadnyk; T L Gillan; R Anderson
Journal:  Cell Immunol       Date:  1997-03-15       Impact factor: 4.868

9.  Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells.

Authors:  A M Zeiher; B Fisslthaler; B Schray-Utz; R Busse
Journal:  Circ Res       Date:  1995-06       Impact factor: 17.367

10.  Interleukin-1 alpha mediates the enhanced expression of intercellular adhesion molecule-1 in pulmonary epithelial cells infected with respiratory syncytial virus.

Authors:  J A Patel; M Kunimoto; T C Sim; R Garofalo; T Eliott; S Baron; O Ruuskanen; T Chonmaitree; P L Ogra; F Schmalstieg
Journal:  Am J Respir Cell Mol Biol       Date:  1995-11       Impact factor: 6.914

View more
  27 in total

1.  Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysis.

Authors:  Susu Duan; David A Boltz; Jiang Li; Christine M Oshansky; Henju Marjuki; Subrata Barman; Richard J Webby; Robert G Webster; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

2.  CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells.

Authors:  Tatiana Chirkova; Songbai Lin; Antonius G P Oomens; Kelsey A Gaston; Seyhan Boyoglu-Barnum; Jia Meng; Christopher C Stobart; Calvin U Cotton; Tina V Hartert; Martin L Moore; Assem G Ziady; Larry J Anderson
Journal:  J Gen Virol       Date:  2015-06-25       Impact factor: 3.891

3.  Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective.

Authors:  S Boyoglu-Barnum; S O Todd; J Meng; T R Barnum; T Chirkova; L M Haynes; S J Jadhao; R A Tripp; A G Oomens; M L Moore; L J Anderson
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

4.  Chemokine CXCL1-Mediated Neutrophil Trafficking in the Lung: Role of CXCR2 Activation.

Authors:  Kirti V Sawant; Renling Xu; Robert Cox; Hal Hawkins; Elena Sbrana; Deepthi Kolli; Roberto P Garofalo; Krishna Rajarathnam
Journal:  J Innate Immun       Date:  2015-07-01       Impact factor: 7.349

5.  Antibodies to the central conserved region of respiratory syncytial virus (RSV) G protein block RSV G protein CX3C-CX3CR1 binding and cross-neutralize RSV A and B strains.

Authors:  Youngjoo Choi; Caleb S Mason; Les P Jones; Jackelyn Crabtree; Patricia A Jorquera; Ralph A Tripp
Journal:  Viral Immunol       Date:  2012-05-02       Impact factor: 2.257

6.  Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin.

Authors:  Deepti R Nagarkar; Julie A Poposki; Michael R Comeau; Assel Biyasheva; Pedro C Avila; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2012-05-26       Impact factor: 10.793

7.  In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo.

Authors:  Rémi Villenave; Surendran Thavagnanam; Severine Sarlang; Jeremy Parker; Isobel Douglas; Grzegorz Skibinski; Liam G Heaney; James P McKaigue; Peter V Coyle; Michael D Shields; Ultan F Power
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

8.  Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection.

Authors:  Julie M Fox; Jackelyn M Crabtree; Leo K Sage; S Mark Tompkins; Ralph A Tripp
Journal:  J Interferon Cytokine Res       Date:  2015-03-10       Impact factor: 2.607

9.  Hypothiocyanite produced by human and rat respiratory epithelial cells inactivates extracellular H1N2 influenza A virus.

Authors:  Aaron Gingerich; Lan Pang; Jarod Hanson; Daniel Dlugolenski; Rebecca Streich; Eric R Lafontaine; Tamás Nagy; Ralph A Tripp; Balázs Rada
Journal:  Inflamm Res       Date:  2015-11-25       Impact factor: 4.575

10.  Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses.

Authors:  Tatiana Chirkova; Seyhan Boyoglu-Barnum; Kelsey A Gaston; Fahad M Malik; Steven P Trau; Antonius G P Oomens; Larry J Anderson
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.